Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Saudi Arabia’s ‘prickly prince’ of oil bristles as crude price slides
    • Train crash in India kills more than 260 people
    • Indonesia floats Ukraine peace plan, triggering sharp western criticism
    • US defence chief warns China against risky behaviour in Indo-Pacific
    • Three Israeli soldiers shot dead on Egyptian border
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • AI ripe to shake up private banking, says Israeli entrepreneur
      • Six Glazer siblings could retain Manchester United stakes under Ratcliffe offer
      • More than 400 Grail patients incorrectly told they may have cancer
      • Boiler makers up in arms over UK heat pump targets
      • UBS considers delaying results after Credit Suisse rescue deal
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Saudi Arabia’s ‘prickly prince’ of oil bristles as crude price slides
      • Handful of tech stocks drive diverging measures of S&P 500 performance
      • Wall Street prepares to take on established crypto companies
      • Active management is a sham — no wonder my returns are suspect
      • ‘There needs to be a health warning’: How crypto trading can lead to addiction
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • Management 101: don’t drain a reservoir to find your phone
      • The frictionless life goes on
      • AI has given Palantir its mystique back
      • Jamie Dimon’s Shanghai show points to broader chill in China
      • Will ChatGPT be Homer Simpson’s salvation?
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • The dismal truth about email
      • Can a virtual PA turbocharge your career?
      • ‘Everyone has the right to completely log off’: what bosses think about the right to disconnect
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Cristiano Ronaldo vs Lionel Messi: who was the greatest footballer?
      • Why motorcycle gangs will end with a whimper, not a rev
      • Sci-fi writer Ted Chiang: ‘The machines we have now are not conscious’
      • Trump or not, US meltdown could be inevitable
      • The American luxury lifestyle brand storming the Cotswolds
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Reckitt Benckiser Group PLC

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Wednesday, 26 April, 2023
      Reckitt picks Kris Licht as new chief

      Former health division head to replace interim boss Nicandro Durante at UK household products group

    • Friday, 3 March, 2023
      Investments
      Investors’ Chronicle: Unite Group, Travis Perkins, Reckitt Benckiser

      Companies analysis from our sister publication

    • Wednesday, 1 March, 2023
      Reckitt Benckiser’s sales volumes slide as demand for disinfectant wanes

      Maker of Durex and Nurofen says sales also affected by tough price negotiations with retailers

    • Tuesday, 3 January, 2023
      Pharmaceuticals sector
      Surge in colds and flu boosts medicine sales

      Demand for over-the-counter remedies rises as rebound in seasonal illnesses combines with Covid-19

    • Wednesday, 26 October, 2022
      Households forgo air fresheners and vitamins in cost of living squeeze

      Reckitt Benckiser becomes latest consumer goods group to report falling sales volumes

    • Thursday, 1 September, 2022
      Starbucks Corp
      Starbucks names departing Reckitt chief as next CEO

      Laxman Narasimhan to take the reins of coffee chain from interim leader Howard Schultz

    • Thursday, 1 September, 2022
      Lex
      Reckitt Benckiser: surprise CEO departure causes market shivers Premium content

      Early exit of Laxman Narasimhan from the consumer goods group will concern shareholders

    • Thursday, 1 September, 2022
      Reckitt Benckiser chief Laxman Narasimhan to step down

      Former head of BAT to take over while consumer group seeks permanent replacement

    • Wednesday, 27 July, 2022
      Health sector
      Reckitt gains from rising medicine sales as Covid-19 beds in

      Strepsils-maker and rival Haleon benefit from over-the-counter treatments boost from Omicron, colds and flu

    • Wednesday, 27 July, 2022
      LexHaleon
      Haleon/Reckitt Benckiser: Covid offers cold cure makers a long-lasting boost Premium content

      Colds and flu are back, and so is demand for remedies

    • Thursday, 30 June, 2022
      Lex
      Reckitt Benckiser: infant formula sale is in jeopardy but sales are rising Premium content

      Company’s guidance for 2022 organic sales growth at the upper end of 1-4 per cent may climb

    • Thursday, 30 June, 2022
      US retail
      US baby formula crisis spurs debate over lack of competition

      Shortage following Abbott safety scandal draws scrutiny of sector dominated by just two companies

    • Wednesday, 22 June, 2022
      Democrats question Reckitt Benckiser’s plan to sell baby formula unit

      US lawmakers warn a deal with private equity group could ‘shallow out’ market already gripped by critical shortages

    • Friday, 29 April, 2022
      Reckitt Benckiser price rises help offset falling demand for disinfectants

      UK consumer products group among several companies that have started passing on commodity cost increases to customers

    • Tuesday, 26 April, 2022
      Reckitt Benckiser seeks up to $10bn for remainder of infant milk business

      Consumer group has written off £8bn after failed takeover

    • Thursday, 17 February, 2022
      Reckitt vows to protect profit through price rises

      Shares in UK disinfectant maker climb after it reassures investors it can absorb surging cost inflation

    • Friday, 24 December, 2021
      Reckitt to sell E45 skincare brand for £200m

      Sale to Swedish group Karo Pharma is part of UK company’s bid to focus on higher-growth areas

    • Tuesday, 26 October, 2021
      Return of colds and flu boosts Reckitt Benckiser

      More social mixing has increased seasonal illnesses and demand for over-the-counter remedies

    • Tuesday, 27 July, 2021
      Reckitt Benckiser shares hit as boom in cleaning products moderates

      Household products group also warns that commodity cost pressures are intensifying

    • Sunday, 20 June, 2021
      News in-depth
      Reckitt chief signals new era with sale of China baby formula unit

      Laxman Narasimhan is hoping to use pandemic surge in demand to restore competitiveness

    • Saturday, 5 June, 2021
      Personal & Household Goods
      Reckitt Benckiser to sell China baby formula business in $2.2bn deal

      Division has weighed on the consumer goods company’s growth for several years

    • Wednesday, 28 April, 2021
      Bryce Elder
      Covid has only delayed the day of reckoning for Reckitt

      Dettol and Lysol maker may look squeaky clean in pandemic but growth is getting tougher to deliver

    • Wednesday, 28 April, 2021
      Reckitt sales beat forecasts as Covid disinfectant boom persists

      Sales of hygiene products jump 29% as consumers keep homes clean

    • Friday, 26 March, 2021
      City InsiderBryce Elder
      Reckitt concedes defeat in makeover racket

      Abandoning its campaign to be recognised as RB continues longstanding identity crisis

    • Friday, 26 February, 2021
      Investments
      Investors’ Chronicle: Reckitt Benckiser, HSBC, BAE Systems

      Companies analysis from our sister publication

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsFT Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In